Preoperative imaging for colorectal liver metastases: a nationwide population-based study.


Journal

BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685

Informations de publication

Date de publication:
08 2020
Historique:
received: 20 01 2020
accepted: 24 03 2020
pubmed: 7 5 2020
medline: 18 9 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

In patients with colorectal liver metastases (CRLM) preoperative imaging may include contrast-enhanced (ce) MRI and [ Data for all patients who underwent liver resection for CRLM in the Netherlands between 2014 and 2018 were retrieved from a nationwide auditing database. Multivariable logistic regression analysis was used to assess use of ceMRI, A total of 4510 patients were included, of whom 1562 had ceMRI, 872 had Significant variation exists concerning the use of preoperative imaging for CRLM between hospitals and oncological networks in the Netherlands. The use of MRI is increasing, whereas that of En pacientes con metástasis hepáticas colorrectales (colorrectal liver metastases, CRLM), los estudios de imagen preoperatorios pueden incluir resonancia magnética con contraste (ce)MRI y En total, se incluyeron 4.510 pacientes, de los cuales 1.562 se sometieron a ceMRI, 872 a

Sections du résumé

BACKGROUND
In patients with colorectal liver metastases (CRLM) preoperative imaging may include contrast-enhanced (ce) MRI and [
METHODS
Data for all patients who underwent liver resection for CRLM in the Netherlands between 2014 and 2018 were retrieved from a nationwide auditing database. Multivariable logistic regression analysis was used to assess use of ceMRI,
RESULTS
A total of 4510 patients were included, of whom 1562 had ceMRI, 872 had
DISCUSSION
Significant variation exists concerning the use of preoperative imaging for CRLM between hospitals and oncological networks in the Netherlands. The use of MRI is increasing, whereas that of
ANTECEDENTES
En pacientes con metástasis hepáticas colorrectales (colorrectal liver metastases, CRLM), los estudios de imagen preoperatorios pueden incluir resonancia magnética con contraste (ce)MRI y
RESULTADOS
En total, se incluyeron 4.510 pacientes, de los cuales 1.562 se sometieron a ceMRI, 872 a

Autres résumés

Type: Publisher (spa)
En pacientes con metástasis hepáticas colorrectales (colorrectal liver metastases, CRLM), los estudios de imagen preoperatorios pueden incluir resonancia magnética con contraste (ce)MRI y

Identifiants

pubmed: 32374497
doi: 10.1002/bjs5.50291
pmc: PMC7397351
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-621

Informations de copyright

© 2020 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of British Journal of Surgery Society.

Références

Acta Radiol. 2016 Sep;57(9):1040-8
pubmed: 26622057
Gut. 2006 Aug;55 Suppl 3:iii1-8
pubmed: 16835351
Int J Clin Oncol. 2020 Jan;25(1):1-42
pubmed: 31203527
BMC Med Imaging. 2014 Aug 08;14:27
pubmed: 25103913
Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1126-1130
pubmed: 28678043
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):152-63
pubmed: 25319712
Neth J Med. 2007 Jan;65(1):5-14
pubmed: 17293634
HPB (Oxford). 2019 Oct;21(10):1400-1410
pubmed: 30926330
JAMA. 2014 May 14;311(18):1863-9
pubmed: 24825641
Ann Surg. 2011 Apr;253(4):666-71
pubmed: 21475005
PET Clin. 2015 Jul;10(3):327-43
pubmed: 26099670
Ann Surg Oncol. 2012 Sep;19(9):2805-13
pubmed: 22396005
Neth J Med. 2006 May;64(5):147-51
pubmed: 16702613
Cureus. 2019 Jan 23;11(1):e3940
pubmed: 30937238
BMC Med Imaging. 2018 Nov 15;18(1):44
pubmed: 30442100
Ann Nucl Med. 2017 Feb;31(2):153-162
pubmed: 27848159
Ann R Coll Surg Engl. 2014 Apr;96(3):211-5
pubmed: 24780786
Wien Klin Wochenschr. 2018 Nov;130(21-22):665-672
pubmed: 30167887
Eur J Surg Oncol. 2020 Sep;46(9):1742-1755
pubmed: 32303416
Radiology. 2010 Dec;257(3):674-84
pubmed: 20829538
HPB (Oxford). 2018 Dec;20(12):1157-1162
pubmed: 29929785
J Magn Reson Imaging. 2018 May;47(5):1237-1250
pubmed: 28901685
BMC Gastroenterol. 2019 Jul 24;19(1):129
pubmed: 31340755
Br J Cancer. 2014 Aug 12;111(4):667-73
pubmed: 24983362
Br J Radiol. 2018 Jan;91(1081):20170216
pubmed: 29034693
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Colorectal Dis. 2013 Nov;15(11):1361-6
pubmed: 23773574
BJS Open. 2019 Aug 19;3(6):857-864
pubmed: 31832593
J Am Coll Radiol. 2005 Jun;2(6):511-9
pubmed: 17411868
Eur Radiol. 2018 Nov;28(11):4735-4747
pubmed: 29736846

Auteurs

A K E Elfrink (AKE)

Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.
Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands.

M Pool (M)

Department of Surgery, Amsterdam University Medical Centre, Cancer Centre Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Department of Radiology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.

L R van der Werf (LR)

Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.
Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

E Marra (E)

Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.

M C Burgmans (MC)

Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands.

M R Meijerink (MR)

Department of Interventional Radiology, Amsterdam University Medical Centre, Cancer Centre Amsterdam, Vrije Universiteit, Amsterdam, the Netherlands.

M den Dulk (M)

Departments of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.

P B van den Boezem (PB)

Radboud Medical Centre, Nijmegen, the Netherlands.

W W Te Riele (WW)

University Medical Centre Utrecht, Utrecht, the Netherlands.
St Antonius Hospital, Nieuwegein, the Netherlands.

G A Patijn (GA)

Isala, Zwolle, the Netherlands.

M W J M Wouters (MWJM)

Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.

W K G Leclercq (WKG)

Máxima Medical Centre, Veldhoven, the Netherlands.

M S L Liem (MSL)

Medisch Spectrum Twente, Enschede, the Netherlands.

P D Gobardhan (PD)

Amphia Medical Centre, Breda, the Netherlands.

C I Buis (CI)

Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands.

K F D Kuhlmann (KFD)

Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.

C Verhoef (C)

Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

M G Besselink (MG)

Department of Surgery, Amsterdam University Medical Centre, Cancer Centre Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.

D J Grünhagen (DJ)

Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

J M Klaase (JM)

Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands.

N F M Kok (NFM)

Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH